Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CCC Intelligent Soln Holdings Inc | Lauren Young | Director | Sale of securities on an exchange or to another person at price $ 7.76 per share. | 07 Nov 2025 | 27,391,934 | 0 | - | 7.8 | 212,618,931 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 7.76 per share. | 07 Nov 2025 | 27,391,934 | 0 | - | 7.8 | 212,618,931 | Common Stock |
| Evommune Inc | Felice Weegen Isabel Verduyn-van | Director, Ten Percent Owner | 07 Nov 2025 | 15,493,466 | 0 | - | - | Series A Preferred Stock | ||
| CCC Intelligent Soln Holdings Inc | Lauren Young | Director | Sale of securities on an exchange or to another person at price $ 7.76 per share. | 07 Nov 2025 | 9,084,247 | 0 | - | 7.8 | 70,512,834 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 7.76 per share. | 07 Nov 2025 | 9,084,247 | 0 | - | 7.8 | 70,512,834 | Common Stock |
| Golden Matrix Grp Inc | Aleksandar Milovanovic | Ten Percent Owner, Member of 10% Reporting Group | Other type of transaction at price $ 1.00 per share. | 07 Nov 2025 | 8,000,000 | 93,328,294 | - | 1 | 8,000,000 | Common Stock |
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 7,230,283 | 0 | - | - | Series A Preferred Stock | ||
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 7,145,647 | 0 | - | - | Series Seed Preferred Stock | ||
| Evommune Inc | Felice Weegen Isabel Verduyn-van | Director, Ten Percent Owner | 07 Nov 2025 | 6,585,011 | 0 | - | - | Series C Preferred Stock | ||
| Evommune Inc | Felice Weegen Isabel Verduyn-van | Director, Ten Percent Owner | 07 Nov 2025 | 5,090,000 | 0 | - | - | Series B Preferred Stock | ||
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 3,572,816 | 0 | - | - | Series Seed Preferred Stock | ||
| Evommune Inc | Felice Weegen Isabel Verduyn-van | Director, Ten Percent Owner | 07 Nov 2025 | 3,367,133 | 3,367,133 | - | - | Common Stock | ||
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 2,582,243 | 0 | - | - | Series A Preferred Stock | ||
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 2,508,575 | 0 | - | - | Series C Preferred Stock | ||
| Billiontoone Inc Ordinary | David Tsao | Director, Chief Technology Officer | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 2,325,108 | 2,325,108 | - | - | Class A Common Stock | |
| Billiontoone Inc Ordinary | David Tsao | Director, Chief Technology Officer | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 2,325,108 | 0 | - | - | Class A Common Stock | |
| Billiontoone Inc Ordinary | David Tsao | Director, Chief Technology Officer | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 2,325,108 | 0 | - | - | Common Stock | |
| Billiontoone Inc Ordinary | David Tsao | Director, Chief Technology Officer | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 2,325,108 | 2,325,108 | - | - | Class B Common Stock | |
| Smith Micro Software Inc | William W. Smith | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 2,236,136 | 2,236,136 | - | - | Common stock purchase warrant | |
| Smith Micro Software Inc | William W. Smith | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.67 per share. | 07 Nov 2025 | 2,236,136 | 5,592,968 (14%) | 5% | 0.7 | 1,500,000 | Common Stock |
| Billiontoone Inc Ordinary | Oguzhan Atay | Director, See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 2,227,542 | 0 | - | - | Class A Common Stock | |
| Billiontoone Inc Ordinary | Oguzhan Atay | Director, See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 2,227,542 | 2,227,542 | - | - | Class B Common Stock | |
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 2,104,740 | 0 | - | - | Series B Preferred Stock | ||
| Billiontoone Inc Ordinary | Oguzhan Atay | Director, See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 1,965,108 | 0 | - | - | Common Stock | |
| Billiontoone Inc Ordinary | Oguzhan Atay | Director, See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 1,965,108 | 2,227,542 | - | - | Class A Common Stock | |
| Hims & Hers Health Inc (Class A) | Andrew Dudum | Director, Chief Executive Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2025 | 1,954,379 | 3,004,071 | - | 0 | Class A Common Stock | |
| Hims & Hers Health Inc (Class A) | Andrew Dudum | Director, Chief Executive Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2025 | 1,954,379 | 0 | - | 0 | Class A Common Stock | |
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 1,895,260 | 0 | - | - | Series B Preferred Stock | ||
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 1,632,441 | 1,632,441 | - | - | Common Stock | ||
| Evommune Inc | Felice Weegen Isabel Verduyn-van | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 07 Nov 2025 | 1,562,500 | 4,929,633 | - | 16 | 25,000,000 | Common Stock |
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 1,441,032 | 1,441,032 | - | - | Common Stock | ||
| Robinhood Markets Inc (Class A) | Baiju Bhatt | Director | 07 Nov 2025 | 1,330,000 | 1,330,000 | - | - | Class A Common Stock | ||
| Robinhood Markets Inc (Class A) | Baiju Bhatt | Director | 07 Nov 2025 | 1,330,000 | 47,682,514 | - | - | Class B Common Stock | ||
| Hims & Hers Health Inc (Class A) | Andrew Dudum | Director, Chief Executive Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2025 | 1,049,692 | 1,049,692 | - | 0 | Class A Common Stock | |
| Hims & Hers Health Inc (Class A) | Andrew Dudum | Director, Chief Executive Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2025 | 1,049,692 | 0 | - | 0 | Class A Common Stock | |
| Billiontoone Inc Ordinary | Oguzhan Atay | Director, See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 1,003,102 | 1,003,102 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Oguzhan Atay | Director, See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 1,003,102 | 0 | - | - | Stock Option (right to buy) | |
| Snap Inc (Class A) | Robert Murphy | Director, Chief Technology Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 07 Nov 2025 | 1,000,000 | 51,911,126 (4%) | 0% | 8.0 | 8,003,700 | Class A Common Stock |
| CCC Intelligent Soln Holdings Inc | Lauren Young | Director | Sale of securities on an exchange or to another person at price $ 7.76 per share. | 07 Nov 2025 | 866,345 | 0 | - | 7.8 | 6,724,657 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 7.76 per share. | 07 Nov 2025 | 866,345 | 0 | - | 7.8 | 6,724,657 | Common Stock |
| Billiontoone Inc Ordinary | Oguzhan Atay | Director, See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 640,000 | 0 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Oguzhan Atay | Director, See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 640,000 | 640,000 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | David Tsao | Director, Chief Technology Officer | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 640,000 | 640,000 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | David Tsao | Director, Chief Technology Officer | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 640,000 | 0 | - | - | Stock Option (right to buy) | |
| Robinhood Markets Inc (Class A) | Baiju Bhatt | Director | Sale of securities on an exchange or to another person at price $ 127.97 per share. | 07 Nov 2025 | 630,852 | 699,148 | - | 128.0 | 80,728,364 | Class A Common Stock |
| Robinhood Markets Inc (Class A) | Baiju Bhatt | Director | Sale of securities on an exchange or to another person at price $ 128.66 per share. | 07 Nov 2025 | 559,473 | 139,675 | - | 128.7 | 71,982,020 | Class A Common Stock |
| Billiontoone Inc Ordinary | David Tsao | Director, Chief Technology Officer | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 501,551 | 0 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | David Tsao | Director, Chief Technology Officer | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 501,551 | 501,551 | - | - | Stock Option (right to buy) | |
| BeiGene Ltd (ADR) | Xiaodong Wang | Director, Chair, Scientific Advisory Brd | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2025 | 424,073 | 4,582,601 (0%) | 0% | 0 | Ordinary Shares | |
| DENTSPLY Sirona Inc | Robert Anthony Johnson | SVP, Chief Supply Chain Office | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 417,200 | 417,200 | - | - | Stock Option (Right to Buy) | |
| ThredUp Inc (Class A) | James Reinhart | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 7.93 per share. | 07 Nov 2025 | 379,826 | 573,851 | - | 7.9 | 3,012,780 | Class A Common Stock |
| DENTSPLY Sirona Inc | Robert Anthony Johnson | SVP, Chief Supply Chain Office | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 361,700 | 361,700 | - | - | Stock Option (Right to Buy) | |
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 313,571 | 0 | - | - | Series C Preferred Stock | ||
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 313,571 | 0 | - | - | Series C Preferred Stock | ||
| Comtech Telecom Corp | Kenneth H. Traub | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 307,018 | 470,953 | - | - | Restricted Stock Units | |
| Snap Inc (Class A) | Robert Murphy | Director, Chief Technology Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2025 | 297,349 | 51,613,777 (4%) | 0% | 0 | Class A Common Stock | |
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 294,502 | 294,502 | - | - | Common Stock | ||
| Billiontoone Inc Ordinary | Oguzhan Atay | Director, See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 262,434 | 262,434 | - | - | Class A Common Stock | |
| Billiontoone Inc Ordinary | Oguzhan Atay | Director, See Remarks | 07 Nov 2025 | 262,434 | 0 | - | - | Series A-1 Convertible Preferred Stock | ||
| Billiontoone Inc Ordinary | Oguzhan Atay | Director, See Remarks | 07 Nov 2025 | 262,434 | 262,434 | - | - | Common Stock | ||
| Billiontoone Inc Ordinary | Oguzhan Atay | Director, See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 262,434 | 0 | - | - | Common Stock | |
| Hims & Hers Health Inc (Class A) | Andrew Dudum | Director, Chief Executive Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2025 | 262,423 | 262,423 | - | 0 | Class A Common Stock | |
| Hims & Hers Health Inc (Class A) | Andrew Dudum | Director, Chief Executive Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2025 | 262,423 | 0 | - | 0 | Class A Common Stock | |
| Hims & Hers Health Inc (Class A) | Andrew Dudum | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 260,000 | 2,423 | - | 0 | Class A Common Stock | |
| Energizer Holdings Inc | Mark Stephen LaVigne | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 254,185 | 566,858 (0%) | 0% | 0 | Common Stock | |
| Paramount Skydance Corp (Class B) | Jeffrey S. Shell | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 250,000 | 4,750,000 | - | - | Restricted Stock Units | |
| Paramount Skydance Corp (Class B) | Jeffrey S. Shell | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 250,000 | 250,000 (0%) | 0% | 0 | Class B common stock | |
| Paramount Skydance Corp (Class B) | David Ferris Ellison | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 250,000 | 4,750,000 | - | - | Restricted Stock Units | |
| Paramount Skydance Corp (Class B) | David Ferris Ellison | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 250,000 | 250,000 (0%) | 0% | 0 | Class B common stock | |
| Information Services Grp Inc | Michael P. Connors | Director, CHAIRMAN & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.47 per share. | 07 Nov 2025 | 248,935 | 5,284,797 (11%) | 0% | 5.5 | 1,361,674 | Shares of Common Stock |
| BETA Technologies Inc | Kyle Clark | Director, SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 244,379 | 484,962 | - | 0 | Class A common stock | |
| Billiontoone Inc Ordinary | Shan Riku Sakakibara | Chief Product Officer | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 220,000 | 220,000 | - | - | Class A Common Stock | |
| Billiontoone Inc Ordinary | Shan Riku Sakakibara | Chief Product Officer | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 220,000 | 0 | - | - | Common Stock | |
| Evommune Inc | Eugene A. Bauer | Director, Chief Medical Officer | 07 Nov 2025 | 206,355 | 0 | - | - | Series Seed Preferred Stock | ||
| Evommune Inc | Luis C. Pena | Director, President & CEO | 07 Nov 2025 | 206,355 | 0 | - | - | Series Seed Preferred Stock | ||
| BETA Technologies Inc | John Stephen Slattery | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 203,648 | 266,445 | - | 0 | Class A common stock | |
| Roivant Sciences Ltd | Eric Venker | President & Immunovant CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 200,000 | 6,076,523 | - | - | Stock Option (Right to Buy) | |
| Roivant Sciences Ltd | Eric Venker | President & Immunovant CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.85 per share. | 07 Nov 2025 | 200,000 | 1,704,959 | - | 3.9 | 770,000 | Common Shares |
| Roivant Sciences Ltd | Eric Venker | President & Immunovant CEO | Sale of securities on an exchange or to another person at price $ 20.22 per share. | 07 Nov 2025 | 200,000 | 1,504,959 | - | 20.2 | 4,044,000 | Common Shares |
| ThredUp Inc (Class A) | James Reinhart | Director, Chief Executive Officer | 07 Nov 2025 | 200,000 | 200,000 | - | 0 | Common Stock | ||
| ThredUp Inc (Class A) | James Reinhart | Director, Chief Executive Officer | 07 Nov 2025 | 200,000 | 2,383,795 | - | - | Class B Common Stock | ||
| ThredUp Inc (Class A) | James Reinhart | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 7.95 per share. | 07 Nov 2025 | 200,000 | 0 | - | 7.9 | 1,589,840 | Common Stock |
| Billiontoone Inc Ordinary | Oguzhan Atay | Director, See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 200,000 | 0 | - | - | Common Stock | |
| Billiontoone Inc Ordinary | Oguzhan Atay | Director, See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 200,000 | 200,000 | - | - | Class A Common Stock | |
| Paramount Skydance Corp (Class B) | Andrew Brandon Gordon | Director, Chief Strategy Officer and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 200,000 | 200,000 (0%) | 0% | 0 | Class B common stock | |
| Paramount Skydance Corp (Class B) | Andrew Brandon Gordon | Director, Chief Strategy Officer and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 200,000 | 3,800,000 | - | - | Restricted Stock Units | |
| Mawson infra Grp Inc | Ryan Costello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 197,570 | 197,570 | - | - | Restricted Stock Units | |
| Billiontoone Inc Ordinary | Ross Taylor | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 175,000 | 0 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Ross Taylor | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 175,000 | 175,000 | - | - | Stock Option (right to buy) | |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 169,582 | 1,437,390 (0%) | 0% | - | Common Stock | |
| Fox Corp (Class A) | Keith Rupert Murdoch | Chairman Emeritus | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 168,756 | 0 | - | - | Stock Option (Right to Buy) | |
| Fox Corp (Class A) | Keith Rupert Murdoch | Chairman Emeritus | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.50 per share. | 07 Nov 2025 | 168,756 | 168,756 (0%) | 0% | 33.5 | 5,653,326 | Class A Common Stock |
| Fox Corp (Class A) | Keith Rupert Murdoch | Chairman Emeritus | Sale of securities on an exchange or to another person at price $ 65.97 per share. | 07 Nov 2025 | 168,756 | 0 (0%) | 0% | 66.0 | 11,132,833 | Class A Common Stock |
| QuantumScape Corp (Class A) | Michael O. McCarthy | CHIEF LEGAL OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2025 | 158,323 | 1,217,795 | - | 0 | Class A Common Stock | |
| QuantumScape Corp (Class A) | Michael O. McCarthy | CHIEF LEGAL OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2025 | 158,323 | 158,323 | - | 0 | Class A Common Stock | |
| Energizer Holdings Inc | Mark Stephen LaVigne | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 158,271 | 158,271 | - | - | Restricted Stock Unit Award 11/10/2025 | |
| Mawson infra Grp Inc | Kathryn Yingling Schellenger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 156,619 | 156,619 | - | - | Restricted Stock Units | |
| Comtech Telecom Corp | Michael A. Bondi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 148,026 | 195,054 | - | - | Restricted Stock Units | |
| Mawson infra Grp Inc | Steven Soles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 138,053 | 174,241 | - | - | Restricted Stock Units | |
| Astrazeneca PLC (ADR) | Pascal Soriot | Executive Director,Chief Executive Officer | 07 Nov 2025 | 136,537 | 522,935 (0%) | 0% | 0 | Ords 0.25p | ||
| Astrazeneca PLC (ADR) | Pascal Soriot | Executive Director,Chief Executive Officer | 07 Nov 2025 | 136,537 | 386,398 (0%) | 0% | 0 | Ords 0.25p | ||
| Billiontoone Inc Ordinary | John D. Lister | Chief Administrative Officer | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 133,300 | 0 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | John D. Lister | Chief Administrative Officer | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 133,300 | 133,300 | - | - | Stock Option (right to buy) | |
| Paramount Skydance Corp (Class B) | David Ferris Ellison | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.10 per share. | 07 Nov 2025 | 126,950 | 123,050 (0%) | 0% | 15.1 | 1,916,945 | Class B common stock |
| Billiontoone Inc Ordinary | Nancy JoAnn Johnson | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Nancy JoAnn Johnson | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 125,000 | 0 | - | - | Stock Option (right to buy) | |
| Comtech Telecom Corp | Daniel Gizinski | President, S&S Comm. Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 119,243 | 146,454 | - | - | Restricted Stock Units | |
| Paramount Skydance Corp (Class B) | Jeffrey S. Shell | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.10 per share. | 07 Nov 2025 | 117,017 | 132,983 (0%) | 0% | 15.1 | 1,766,957 | Class B common stock |
| Energizer Holdings Inc | Mark Stephen LaVigne | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.82 per share. | 07 Nov 2025 | 111,969 | 454,889 (0%) | 0% | 23.8 | 2,667,102 | Common Stock |
| Comtech Telecom Corp | Donald E. Walther | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 106,908 | 175,354 | - | - | Restricted Stock Units | |
| Comtech Telecom Corp | Jeffery Paul Robertson | President, Allerium Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 106,908 | 206,649 | - | - | Restricted Stock Units | |
| Robinhood Markets Inc (Class A) | Baiju Bhatt | Director | Sale of securities on an exchange or to another person at price $ 129.78 per share. | 07 Nov 2025 | 104,998 | 34,677 | - | 129.8 | 13,626,388 | Class A Common Stock |
| Information Services Grp Inc | Michael P. Connors | Director, CHAIRMAN & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.21 per share. | 07 Nov 2025 | 100,096 | 5,106,225 (10%) | 0% | 5.2 | 521,500 | Shares of Common Stock |
| Corsair Gaming Inc | Samuel R. Szteinbaum | Director | Purchase of securities on an exchange or from another person at price $ 6.59 per share. | 07 Nov 2025 | 100,000 | 420,267 | - | 6.6 | 658,770 | Common Stock |
| Las Vegas Sands | D. Zachary Hudson | EVP and Global General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 100,000 | 400,000 | - | - | Option (Right to Buy) | |
| Las Vegas Sands | D. Zachary Hudson | EVP and Global General Counsel | Sale of securities on an exchange or to another person at price $ 64.99 per share. | 07 Nov 2025 | 100,000 | 13,735 (0%) | 0% | 65.0 | 6,499,000 | Common Stock |
| Las Vegas Sands | D. Zachary Hudson | EVP and Global General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.28 per share. | 07 Nov 2025 | 100,000 | 113,735 (0%) | 0% | 34.3 | 3,428,000 | Common Stock |
| Paramount Skydance Corp (Class B) | Andrew Brandon Gordon | Director, Chief Strategy Officer and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.10 per share. | 07 Nov 2025 | 91,627 | 108,373 (0%) | 0% | 15.1 | 1,383,568 | Class B common stock |
| Wheels Up Experience Inc (Class A) | Mark Briffa | Chief Sales Officer | Sale of securities on an exchange or to another person at price $ 1.23 per share. | 07 Nov 2025 | 86,813 | 866,670 | - | 1.2 | 106,780 | Class A Common Stock, par value $0.0001 per share |
| Enviri Corp | Tom George Vadaketh | SVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 84,746 | 216,920 | - | - | Restricted Stock Units | |
| Enviri Corp | Tom George Vadaketh | SVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 84,746 | 217,177 (0%) | 0% | 0 | Common Stock | |
| Billiontoone Inc Ordinary | Thomas P. Lynch | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 79,400 | 79,400 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Thomas P. Lynch | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 79,400 | 0 | - | - | Stock Option (right to buy) | |
| Information Services Grp Inc | Michael P. Connors | Director, CHAIRMAN & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.22 per share. | 07 Nov 2025 | 78,476 | 5,206,321 (10%) | 0% | 5.2 | 409,645 | Shares of Common Stock |
| Sonos Inc | Julius Genachowski | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2025 | 77,057 | 77,057 (0%) | 0% | 0 | Common Stock | |
| Sonos Inc | Julius Genachowski | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2025 | 77,057 | 51,705 (0%) | 0% | 0 | Common Stock | |
| Billiontoone Inc Ordinary | Ross Taylor | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Ross Taylor | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 75,000 | 0 | - | - | Stock Option (right to buy) | |
| Immucell Corp | Paul Francis Olivier te Boekhorst | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 74,277 | 150,260 | - | - | Stock Options (right to buy) | |
| Energizer Holdings Inc | John J. Drabik | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 68,757 | 125,234 (0%) | 0% | 0 | Common Stock | |
| Femasys Inc | Kathy Lee-Sepsick | Director, Chief Executive Officer | 07 Nov 2025 | 68,244 | 68,244 | - | - | Series C-1 Warrants | ||
| Femasys Inc | Kathy Lee-Sepsick | Director, Chief Executive Officer | 07 Nov 2025 | 68,244 | 68,244 | - | - | Series A-1 Warrants | ||
| Femasys Inc | Kathy Lee-Sepsick | Director, Chief Executive Officer | 07 Nov 2025 | 68,244 | 68,244 | - | - | Series B-1 Warrants | ||
| Information Services Grp Inc | Michael P. Connors | Director, CHAIRMAN & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.26 per share. | 07 Nov 2025 | 66,196 | 5,040,029 (10%) | 0% | 5.3 | 348,191 | Shares of Common Stock |
| Billiontoone Inc Ordinary | Shan Riku Sakakibara | Chief Product Officer | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 65,000 | 0 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Shan Riku Sakakibara | Chief Product Officer | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 65,000 | 65,000 | - | - | Stock Option (right to buy) | |
| Energizer Holdings Inc | Mark Stephen LaVigne | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 62,607 | 340,252 (0%) | 0% | 0 | Common Stock | |
| Energizer Holdings Inc | Mark Stephen LaVigne | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 62,607 | 0 | - | - | Restricted Stock Unit Award 11/7/2022 | |
| Cronos Grp Inc | Adam Wagner | SVP, Head of Cronos Israel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 60,728 | 138,632 | - | - | RESTRICTED STOCK UNITS | |
| BETA Technologies Inc | David Lawrence Churchill | Director, CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 53,965 | 488,816 | - | 0 | Class A common stock | |
| BETA Technologies Inc | Sean Donovan | Director, CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 53,965 | 112,391 | - | 0 | Class A common stock | |
| SINTX Tech Inc | Gregg R. Honigblum | Director, Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 53,867 | 192,867 (1%) | 0% | 0 | Common Stock | |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.10 per share. | 07 Nov 2025 | 50,405 | 1,267,808 (0%) | 0% | 74.1 | 3,735,011 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 50,291 | 80,583 | - | - | Stock Option (Right to Buy) | |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 18.97 per share. | 07 Nov 2025 | 50,291 | 214,232 (0%) | 0% | 19.0 | 954,066 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.23 per share. | 07 Nov 2025 | 50,291 | 264,523 (0%) | 0% | 1.2 | 61,737 | Common Stock |
| NatWest Grp PLC (ADR) | Paul Thwaite | Executive Director,Chief Executive Officer | 07 Nov 2025 | 50,255 | 1,031,780 (0%) | 0% | 0 | Ords 1.08p | ||
| Imax Corp | Robert Darin Lister | Chief Legal Officer Sr Exec VP | 07 Nov 2025 | 50,143 | 0 | - | - | stock options (to buy) | ||
| Imax Corp | Robert Darin Lister | Chief Legal Officer Sr Exec VP | 07 Nov 2025 | 50,143 | 211,564 (0%) | 0% | 22.5 | 1,127,716 | common shares | |
| Imax Corp | Robert Darin Lister | Chief Legal Officer Sr Exec VP | Sale of securities on an exchange or to another person at price $ 34.67 per share. | 07 Nov 2025 | 50,143 | 161,421 (0%) | 0% | 34.7 | 1,738,217 | common shares |
| Billiontoone Inc Ordinary | Shan Riku Sakakibara | Chief Product Officer | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 50,000 | 0 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Shan Riku Sakakibara | Chief Product Officer | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Revolution Medicines Inc | Mark A. Goldsmith | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2025 | 50,000 | 54,498 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Mark A. Goldsmith | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2025 | 50,000 | 70,424 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Mark A. Goldsmith | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2025 | 50,000 | 247,863 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Mark A. Goldsmith | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2025 | 50,000 | 297,863 (0%) | 0% | 0 | Common Stock | |
| Wheels Up Experience Inc (Class A) | Meaghan Wells | Chief Growth Officer | Sale of securities on an exchange or to another person at price $ 1.22 per share. | 07 Nov 2025 | 47,931 | 526,681 | - | 1.2 | 58,476 | Class A Common Stock, par value $0.0001 per share |
| Hologic | Essex D. Mitchell | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 47,106 | 80,653 (0%) | 0% | - | Common Stock | |
| Lumen Tech Inc | Kathleen E Johnson | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.52 per share. | 07 Nov 2025 | 46,735 | 8,483,897 (0%) | 0% | 10.5 | 491,652 | Common Stock |
| JFrog Ltd | Frederic Simon | Director | Sale of securities on an exchange or to another person at price $ 59.74 per share. | 07 Nov 2025 | 45,461 | 3,994,116 | - | 59.7 | 2,715,840 | Ordinary Shares |
| Alkami Tech Inc | Alex Shootman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 19.45 per share. | 07 Nov 2025 | 45,000 | 841,563 | - | 19.5 | 875,250 | Common Stock |
| Rush Street Interactive Inc (Class A) | Kyle L. Sauers | Chief Financial Officer, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 44,253 | 132,556 | - | - | Stock Option (Right to Buy) | |
| Rush Street Interactive Inc (Class A) | Kyle L. Sauers | Chief Financial Officer, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.99 per share. | 07 Nov 2025 | 44,253 | 514,826 | - | 4.0 | 176,569 | Class A Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.11 per share. | 07 Nov 2025 | 43,950 | 3,743,524 | - | 1.1 | 48,785 | Common Stock |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 43,741 | 153,517 (0%) | 0% | - | Common Stock | |
| Delek US Holdings Inc | Ezra Uzi Yemin | Director | Sale of securities on an exchange or to another person at price $ 43.09 per share. | 07 Nov 2025 | 43,489 | 679,656 (0%) | 0% | 43.1 | 1,873,941 | Common Stock |
| Energizer Holdings Inc | Robin W. Vauth | EVP, International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 41,670 | 57,039 (0%) | 0% | 0 | Common Stock | |
| Energizer Holdings Inc | Michael A Lampman | EVP, NA & Global Bus. Units | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 41,670 | 67,542 (0%) | 0% | 0 | Common Stock | |
| Spero Therapeutics Inc | Esther Rajavelu | See Remarks | Sale of securities on an exchange or to another person at price $ 2.37 per share. | 07 Nov 2025 | 40,270 | 869,450 (4%) | 0% | 2.4 | 95,440 | Common Stock |
| Billiontoone Inc Ordinary | Thomas P. Lynch | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 40,000 | 0 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Thomas P. Lynch | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Nancy JoAnn Johnson | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Nancy JoAnn Johnson | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 40,000 | 0 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Nancy JoAnn Johnson | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Nancy JoAnn Johnson | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 40,000 | 0 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Shan Riku Sakakibara | Chief Product Officer | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Shan Riku Sakakibara | Chief Product Officer | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 40,000 | 0 | - | - | Stock Option (right to buy) | |
| Lemonade Inc | Adina Eckstein | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 40,000 | 13,062 | - | - | STOCK OPTION | |
| Enviri Corp | Tom George Vadaketh | SVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.19 per share. | 07 Nov 2025 | 38,916 | 178,261 (0%) | 0% | 12.2 | 474,386 | Common Stock |
| Sky Quarry Inc | David Sealock | Former CEO | Sale of securities on an exchange or to another person at price $ 0.40 per share. | 07 Nov 2025 | 38,062 | 477,510 | - | 0.4 | 15,225 | Common Shares |
| Energizer Holdings Inc | Lori A. Shambro | EVP, Brand&Product Innovation | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 37,504 | 71,033 (0%) | 0% | 0 | Common Stock | |
| Billiontoone Inc Ordinary | John Roderick ten Bosch | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 37,500 | 37,500 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | John Roderick ten Bosch | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 37,500 | 0 | - | - | Stock Option (right to buy) | |
| JFrog Ltd | Frederic Simon | Director | Sale of securities on an exchange or to another person at price $ 65.09 per share. | 07 Nov 2025 | 37,117 | 3,947,786 | - | 65.1 | 2,415,946 | Ordinary Shares |
| Billiontoone Inc Ordinary | John Roderick ten Bosch | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 37,000 | 0 | - | - | Common Stock | |
| Billiontoone Inc Ordinary | John Roderick ten Bosch | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 37,000 | 37,000 | - | - | Class A Common Stock | |
| RXO Inc | Thomas A. Szlosek | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2025 | 36,508 | 0 | - | 0 | Common Stock | |
| Mawson infra Grp Inc | Steven Soles | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 36,188 | 36,188 | - | - | Common Stock | |
| Mawson infra Grp Inc | Steven Soles | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 36,188 | 138,053 | - | - | Restricted Stock Units | |
| Mawson infra Grp Inc | Steven Soles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 36,188 | 36,188 | - | - | Restricted Stock Units | |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.14 per share. | 07 Nov 2025 | 35,818 | 3,676,534 | - | 1.1 | 40,833 | Common Stock |
| Charles Schwab | Jonathan M. Craig | MD, Head of Investor Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 35,188 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Charles Schwab | Jonathan M. Craig | MD, Head of Investor Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.98 per share. | 07 Nov 2025 | 35,188 | 0 (0%) | 0% | 42.0 | 1,477,192 | Common Stock |
| Charles Schwab | Jonathan M. Craig | MD, Head of Investor Services | Sale of securities on an exchange or to another person at price $ 95.35 per share. | 07 Nov 2025 | 35,188 | 0 (0%) | 0% | 95.3 | 3,355,028 | Common Stock |
| PENN Entertainment Inc | Jay A. Snowden | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 14.32 per share. | 07 Nov 2025 | 34,700 | 1,117,325 (0%) | 0% | 14.3 | 496,939 | Common Stock |
| Robinhood Markets Inc (Class A) | Baiju Bhatt | Director | Sale of securities on an exchange or to another person at price $ 130.54 per share. | 07 Nov 2025 | 34,677 | 0 | - | 130.5 | 4,526,614 | Class A Common Stock |
| NatWest Grp PLC (ADR) | Katie Murray | Executive Director,Chief Financial Officer | 07 Nov 2025 | 34,265 | 827,661 (0%) | 0% | 0 | Ords 1.08p | ||
| Femasys Inc | Charles E. Larsen | Director | 07 Nov 2025 | 34,122 | 34,122 | - | - | Series C-1 Warrants | ||
| Femasys Inc | Charles E. Larsen | Director | 07 Nov 2025 | 34,122 | 34,122 | - | - | Series B-1 Warrants | ||
| Femasys Inc | Charles E. Larsen | Director | 07 Nov 2025 | 34,122 | 34,122 | - | - | Series A-1 Warrants | ||
| Femasys Inc | Dov Elefant | Chief Financial Officer | 07 Nov 2025 | 34,122 | 34,122 | - | - | Series A-1 Warrants | ||
| Femasys Inc | Dov Elefant | Chief Financial Officer | 07 Nov 2025 | 34,122 | 34,122 | - | - | Series C-1 Warrants | ||
| Femasys Inc | Dov Elefant | Chief Financial Officer | 07 Nov 2025 | 34,122 | 34,122 | - | - | Series B-1 Warrants | ||
| Energizer Holdings Inc | Benjamin J. Angelette | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 33,337 | 54,581 (0%) | 0% | 0 | Common Stock | |
| Snowflake Inc (Class A) | Michael L. Speiser | Director | Sale of securities on an exchange or to another person at price $ 257.00 per share. | 07 Nov 2025 | 31,713 | 1,360,185 | - | 257 | 8,150,241 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.18 per share. | 07 Nov 2025 | 31,172 | 3,712,352 | - | 1.2 | 36,783 | Common Stock |
| Energizer Holdings Inc | John J. Drabik | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.82 per share. | 07 Nov 2025 | 30,288 | 94,946 (0%) | 0% | 23.8 | 721,460 | Common Stock |
| Hologic | Jennifer Schneiders | President, Diag. Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 30,282 | 42,581 (0%) | 0% | - | Common Stock | |
| GigaCloud Tech Inc (Class A) | Xinyan Hao | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 30.29 per share. | 07 Nov 2025 | 30,000 | 746,805 | - | 30.3 | 908,835 | Class A Ordinary Shares, par value $0.05 per share |
| Phillips 66 | Kevin J. Mitchell | Exec. VP and CFO | Sale of securities on an exchange or to another person at price $ 138.00 per share. | 07 Nov 2025 | 30,000 | 89,771 (0%) | 0% | 138 | 4,140,000 | Common Stock |
| Amplitude Inc (Class A) | Andrew Casey | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 9.99 per share. | 07 Nov 2025 | 30,000 | 1,160,608 | - | 10.0 | 299,790 | Class A Common Stock |
| Billiontoone Inc Ordinary | John Roderick ten Bosch | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | John Roderick ten Bosch | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 30,000 | 0 | - | - | Stock Option (right to buy) | |
| Lemonade Inc | Timothy E. Bixby | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 75.51 per share. | 07 Nov 2025 | 30,000 | 0 | - | 75.5 | 2,265,300 | COMMON STOCK |
| Revolution Medicines Inc | Mark A. Goldsmith | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 60.31 per share. | 07 Nov 2025 | 30,000 | 347,863 (0%) | 0% | 60.3 | 1,809,306 | Common Stock |
| Energizer Holdings Inc | John J. Drabik | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 29,912 | 29,912 | - | - | Restricted Stock Unit Award 11/10/2025 | |
| Billiontoone Inc Ordinary | Nancy JoAnn Johnson | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 29,000 | 0 | - | - | Common Stock | |
| Billiontoone Inc Ordinary | Nancy JoAnn Johnson | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 29,000 | 29,000 | - | - | Class A Common Stock | |
| Billiontoone Inc Ordinary | John Roderick ten Bosch | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 28,500 | 28,500 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | John Roderick ten Bosch | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 28,500 | 0 | - | - | Stock Option (right to buy) | |
| Strata Critical Medical Inc (Class A) | Melissa M. Tomkiel | Director, Co-CEO and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 27,778 | 276,960 | - | - | Stock Option (right to buy) | |
| Strata Critical Medical Inc (Class A) | Melissa M. Tomkiel | Director, Co-CEO and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.18 per share. | 07 Nov 2025 | 27,778 | 1,400,420 | - | 0.2 | 5,000 | Class A common stock, $0.0001 par value per share |
| Energizer Holdings Inc | Mark Stephen LaVigne | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.84 per share. | 07 Nov 2025 | 27,579 | 312,673 (0%) | 0% | 23.8 | 657,483 | Common Stock |
| Aflac Inc | Audrey Boone Tillman | Sr. Executive Vice President | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2025 | 26,970 | 230,688 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Mark A. Goldsmith | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 07 Nov 2025 | 26,479 | 374,342 (0%) | 0% | 1.1 | 29,656 | Common Stock |
| Revolution Medicines Inc | Mark A. Goldsmith | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 26,479 | 0 | - | - | Stock Option (Right to Buy) | |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.09 per share. | 07 Nov 2025 | 26,101 | 3,650,433 | - | 1.1 | 28,450 | Common Stock |
| Evommune Inc | Eugene A. Bauer | Director, Chief Medical Officer | 07 Nov 2025 | 25,812 | 272,296 | - | - | Common Stock | ||
| Evommune Inc | Robert Hopfner | Director, Ten Percent Owner | 07 Nov 2025 | 25,790 | 0 | - | - | Series Seed Preferred Stock | ||
| Grocery Outlet Holding Corp | Steven K. Wilson | EVP, Chief Purchasing Officer | Sale of securities on an exchange or to another person at price $ 12.53 per share. | 07 Nov 2025 | 25,000 | 116,923 (0%) | 0% | 12.5 | 313,250 | Common Stock |
| Thryv Holdings Inc | Joseph A. Walsh | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 6.51 per share. | 07 Nov 2025 | 25,000 | 610,232 | - | 6.5 | 162,750 | Common Shares |
| Wolverine World Wide Inc | DeMonty Price | Director | Purchase of securities on an exchange or from another person at price $ 15.77 per share. | 07 Nov 2025 | 25,000 | 75,000 (0%) | 0% | 15.8 | 394,250 | Common Stock |
| Billiontoone Inc Ordinary | Nancy JoAnn Johnson | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Nancy JoAnn Johnson | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 25,000 | 0 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Nancy JoAnn Johnson | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Nancy JoAnn Johnson | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 25,000 | 0 | - | - | Stock Option (right to buy) | |
| Evommune Inc | Gregory S. Moss | Chief Business & Legal Officer | 07 Nov 2025 | 25,000 | 0 | - | - | Series B Preferred Stock | ||
| Evommune Inc | Kyle Carver | Chief Financial Officer | 07 Nov 2025 | 25,000 | 0 | - | - | Series B Preferred Stock | ||
| Evommune Inc | Jeegar Pravinkumar Patel | Chief Scientific Officer | 07 Nov 2025 | 25,000 | 0 | - | - | Series B Preferred Stock | ||
| JFrog Ltd | Frederic Simon | Director | Sale of securities on an exchange or to another person at price $ 58.58 per share. | 07 Nov 2025 | 24,674 | 4,039,577 | - | 58.6 | 1,445,403 | Ordinary Shares |
| Evommune Inc | Luis C. Pena | Director, President & CEO | 07 Nov 2025 | 24,225 | 682,821 | - | - | Common Stock | ||
| NatWest Grp PLC (ADR) | Paul Thwaite | Executive Director,Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 6.00 per share. | 07 Nov 2025 | 23,656 | 1,008,124 (0%) | 0% | 6.0 | 141,889 | Ords 1.08p |
| Viavi Soln Inc | Keith L. Barnes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 23,529 | 148,680 (0%) | 0% | 0 | Common Stock | |
| Viavi Soln Inc | Keith L. Barnes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 23,529 | 0 | - | - | Restricted Stock Unit | |
| Viavi Soln Inc | Masood A. Jabbar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 23,529 | 0 | - | - | Restricted Stock Unit | |
| Viavi Soln Inc | Masood A. Jabbar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 23,529 | 203,862 (0%) | 0% | 0 | Common Stock | |
| Viavi Soln Inc | Richard E. Belluzzo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 23,529 | 240,683 (0%) | 0% | 0 | Common Stock | |
| Viavi Soln Inc | Richard E. Belluzzo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 23,529 | 0 | - | - | Restricted Stock Unit | |
| Viavi Soln Inc | Donald A. Colvin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 23,529 | 0 | - | - | Restricted Stock Unit | |
| Viavi Soln Inc | Donald A. Colvin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 23,529 | 172,053 (0%) | 0% | 0 | Common Stock | |
| Viavi Soln Inc | Joanne Solomon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 23,529 | 0 | - | - | Restricted Stock Unit | |
| Viavi Soln Inc | Joanne Solomon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 23,529 | 75,924 (0%) | 0% | 0 | Common Stock | |
| Viavi Soln Inc | Douglas L. Gilstrap | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 23,529 | 65,766 (0%) | 0% | 0 | Common Stock | |
| Viavi Soln Inc | Douglas L. Gilstrap | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 23,529 | 0 | - | - | Restricted Stock Unit | |
| Viavi Soln Inc | Laura A. Black | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 23,529 | 142,497 (0%) | 0% | 0 | Common Stock | |
| Viavi Soln Inc | Laura A. Black | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 23,529 | 0 | - | - | Restricted Stock Unit | |
| General American Investors Co. Inc | Spencer Davidson | Chairman | Purchase of securities on an exchange or from another person at price $ 25.00 per share. | 07 Nov 2025 | 21,610 | 144,197 | - | 25.0 | 540,172 | 5.95% Preferred Stock |
| BETA Technologies Inc | Kyle Clark | Director, SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 21,587 | 21,587 | - | 0 | Class A common stock | |
| GigaCloud Tech Inc (Class A) | Xinyan Hao | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 31.39 per share. | 07 Nov 2025 | 21,300 | 695,505 | - | 31.4 | 668,607 | Class A Ordinary Shares, par value $0.05 per share |
| Liquidia Corp | Dana Boyle | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 25.06 per share. | 07 Nov 2025 | 20,662 | 155,334 (0%) | 0% | 25.1 | 517,790 | Common Stock |
| GigaCloud Tech Inc (Class A) | Xinyan Hao | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 33.77 per share. | 07 Nov 2025 | 20,641 | 716,805 | - | 33.8 | 697,047 | Class A Ordinary Shares, par value $0.05 per share |
| QuantumScape Corp (Class A) | Michael O. McCarthy | CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 16.12 per share. | 07 Nov 2025 | 20,435 | 137,888 | - | 16.1 | 329,441 | Class A Common Stock |
| BETA Technologies Inc | Brian Dunkiel | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 20,362 | 70,078 | - | 0 | Class A common stock | |
| RXO Inc | Thomas A. Szlosek | Director | Purchase of securities on an exchange or from another person at price $ 12.37 per share. | 07 Nov 2025 | 20,308 | 36,508 | - | 12.4 | 251,210 | Common Stock |
| Tandem Diabetes Care Inc | Sandra Beaver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 20,242 | 20,242 | - | - | Restricted Stock Unit | |
| Golden Matrix Grp Inc | Richard B. Christensen | CFO | Purchase of securities on an exchange or from another person at price $ 0.90 per share. | 07 Nov 2025 | 20,000 | 150,000 | - | 0.9 | 18,000 | Common Stock |
| Ormat Tech Inc | Assaf Ginzburg | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 112.72 per share. | 07 Nov 2025 | 20,000 | 4,482 (0%) | 0% | 112.7 | 2,254,500 | Common Stock |
| Boyd Gaming Corp | William R. Boyd | Director | Sale of securities on an exchange or to another person at price $ 80.36 per share. | 07 Nov 2025 | 20,000 | 1,960,447 (1%) | 0% | 80.4 | 1,607,200 | Common Stock |
| Billiontoone Inc Ordinary | Nancy JoAnn Johnson | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Nancy JoAnn Johnson | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 20,000 | 0 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | John Roderick ten Bosch | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 20,000 | 0 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | John Roderick ten Bosch | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Lemonade Inc | Adina Eckstein | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 74.00 per share. | 07 Nov 2025 | 20,000 | 227,987 | - | 74 | 1,480,000 | COMMON STOCK |
| Lemonade Inc | Adina Eckstein | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.35 per share. | 07 Nov 2025 | 20,000 | 247,987 | - | 27.4 | 547,000 | COMMON STOCK |
| Lemonade Inc | Adina Eckstein | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 72.04 per share. | 07 Nov 2025 | 20,000 | 227,987 | - | 72.0 | 1,440,800 | COMMON STOCK |
| Lemonade Inc | Adina Eckstein | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.35 per share. | 07 Nov 2025 | 20,000 | 247,987 | - | 27.4 | 547,000 | COMMON STOCK |
| Phibro Animal Health Corp (Class A) | Jack Bendheim | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 45.81 per share. | 07 Nov 2025 | 19,773 | 20,897 (0%) | 0% | 45.8 | 905,898 | Class A Common Stock |
| Great Elm Cap Corp | Matt Kaplan | CEO and President | Purchase of securities on an exchange or from another person at price $ 7.64 per share. | 07 Nov 2025 | 19,650 | 142,400 (1%) | 0% | 7.6 | 150,126 | Common Stock |
| Air Lease Corp (Class A) | Matthew J. Hart | Director | Sale of securities on an exchange or to another person at price $ 63.78 per share. | 07 Nov 2025 | 19,627 | 40,587 (0%) | 0% | 63.8 | 1,251,734 | Air Lease Corporation - Class A Common Stock |
| Energizer Holdings Inc | Robin W. Vauth | EVP, International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 19,417 | 19,417 | - | - | Restricted Stock Unit Award 11/10/2025 | |
| Energizer Holdings Inc | Michael A Lampman | EVP, NA & Global Bus. Units | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 19,417 | 19,417 | - | - | Restricted Stock Unit Award 11/10/2025 | |
| Rhythm Pharma Inc | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 98.82 per share. | 07 Nov 2025 | 19,351 | 20,814 (0%) | 0% | 98.8 | 1,912,326 | Common Stock |
| Energizer Holdings Inc | Robin W. Vauth | EVP, International | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.82 per share. | 07 Nov 2025 | 19,169 | 37,870 (0%) | 0% | 23.8 | 456,606 | Common Stock |
| TE Connectivity | Heath A. Mitts | Director, EVP & Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2025 | 18,649 | 26,854 (0%) | 0% | 0 | Common Shares | |
| Energizer Holdings Inc | Lori A. Shambro | EVP, Brand&Product Innovation | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 18,367 | 18,367 | - | - | Restricted Stock Unit Award 11/10/2025 | |
| Energizer Holdings Inc | Michael A Lampman | EVP, NA & Global Bus. Units | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.82 per share. | 07 Nov 2025 | 18,356 | 49,186 (0%) | 0% | 23.8 | 437,240 | Common Stock |
| Ormat Tech Inc | Isaac Angel | Director | Sale of securities on an exchange or to another person at price $ 112.42 per share. | 07 Nov 2025 | 18,018 | 29,650 (0%) | 0% | 112.4 | 2,025,668 | Common Stock |
| Energizer Holdings Inc | Benjamin J. Angelette | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 17,843 | 17,843 | - | - | Restricted Stock Unit Award 11/10/2025 | |
| Bioventus Inc (Class A) | Michelle McMurry-Heath | Director | Sale of securities on an exchange or to another person at price $ 7.42 per share. | 07 Nov 2025 | 17,701 | 56,997 (0%) | 0% | 7.4 | 131,255 | Class A Common Stock |
| Hologic | Anne M. Liddy | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 17,496 | 28,980 (0%) | 0% | - | Common Stock | |
| Senseonics Holdings Inc | Timothy T. Goodnow | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 5.87 per share. | 07 Nov 2025 | 17,210 | 661,085 (0%) | 0% | 5.9 | 101,023 | Common Stock |
| Energizer Holdings Inc | John J. Drabik | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 16,935 | 63,937 (0%) | 0% | 0 | Common Stock | |
| Energizer Holdings Inc | John J. Drabik | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 16,935 | 0 | - | - | Restricted Stock Unit Award 11/7/2022 | |
| PGIM High Yield Bond Fund Inc | Brian K. Reid | Director | Sale of securities on an exchange or to another person at price $ 14.41 per share. | 07 Nov 2025 | 16,833 | 3,064 (0%) | 0% | 14.4 | 242,564 | ISD Common Stock |
| Hologic | Jan Verstreken | Group President, International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 16,823 | 134,413 (0%) | 0% | - | Common Stock | |
| Energizer Holdings Inc | Lori A. Shambro | EVP, Brand&Product Innovation | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.82 per share. | 07 Nov 2025 | 16,521 | 54,512 (0%) | 0% | 23.8 | 393,530 | Common Stock |
| Phillips 66 | Kevin J. Mitchell | Exec. VP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 16,400 | 27,200 | - | - | Employee Stock Option (Right to Buy) | |
| Phillips 66 | Kevin J. Mitchell | Exec. VP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 94.85 per share. | 07 Nov 2025 | 16,400 | 106,171 (0%) | 0% | 94.9 | 1,555,540 | Common Stock |
| NatWest Grp PLC (ADR) | Katie Murray | Executive Director,Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.00 per share. | 07 Nov 2025 | 16,129 | 811,532 (0%) | 0% | 6.0 | 96,742 | Ords 1.08p |
| Comerica Inc | James J. Herzog | Senior EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.89 per share. | 07 Nov 2025 | 15,821 | 35,832 (0%) | 0% | 78.9 | 1,248,119 | Common Stock |
| Ecovyst Inc | Susan F. Ward | Director | Sale of securities on an exchange or to another person at price $ 8.40 per share. | 07 Nov 2025 | 15,000 | 78,261 (0%) | 0% | 8.4 | 126,018 | Common Stock |
| Billiontoone Inc Ordinary | Thomas P. Lynch | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 15,000 | 0 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Thomas P. Lynch | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | John Roderick ten Bosch | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | John Roderick ten Bosch | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 15,000 | 0 | - | - | Stock Option (right to buy) | |
| Stem Inc (Class A) | Matthew Tappin | President, Software Products | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 15,000 | 16,872 | - | - | Common Stock, Par Value $0.0001 Per Share | |
| Stem Inc (Class A) | Matthew Tappin | President, Software Products | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 15,000 | 0 | - | - | Restricted Stock Unit | |
| Senseonics Holdings Inc | A. Douglas Roeder | Director | Purchase of securities on an exchange or from another person at price $ 5.83 per share. | 07 Nov 2025 | 15,000 | 99,727 (0%) | 0% | 5.8 | 87,450 | Common Stock |
| Energizer Holdings Inc | Benjamin J. Angelette | Chief Administrative Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.82 per share. | 07 Nov 2025 | 14,685 | 39,896 (0%) | 0% | 23.8 | 349,797 | Common Stock |
| Cinemark Holdings Inc | Melissa Hayes Thomas | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.58 per share. | 07 Nov 2025 | 14,326 | 189,442 (0%) | 0% | 28.6 | 409,437 | Common Stock |
| Netflix | Reed Hastings | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2025 | 14,089 | 2,140,152 (0%) | 0% | 0 | Common Stock | |
| Phibro Animal Health Corp (Class A) | Jack Bendheim | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 44.91 per share. | 07 Nov 2025 | 14,086 | 40,670 (0%) | 0% | 44.9 | 632,560 | Class A Common Stock |
| Stem Inc (Class A) | Saul R. Laureles | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 13,750 | 26,989 | - | - | Common Stock, Par Value $0.0001 Per Share | |
| Stem Inc (Class A) | Saul R. Laureles | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 13,750 | 0 | - | - | Restricted Stock Unit | |
| Stem Inc (Class A) | Michael James Carlson | President, Managed Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 13,750 | 0 | - | - | Restricted Stock Unit | |
| Stem Inc (Class A) | Michael James Carlson | President, Managed Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 13,750 | 24,127 | - | - | Common Stock, Par Value $0.0001 Per Share | |
| Phillips 66 | Kevin J. Mitchell | Exec. VP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 13,600 | 43,600 | - | - | Employee Stock Option (Right to Buy) | |
| Phillips 66 | Kevin J. Mitchell | Exec. VP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.70 per share. | 07 Nov 2025 | 13,600 | 119,771 (0%) | 0% | 74.7 | 1,015,920 | Common Stock |
| Primoris Services Corp | Patricia K. Wagner | Director | Sale of securities on an exchange or to another person at price $ 125.23 per share. | 07 Nov 2025 | 13,491 | 4,495 (0%) | 0% | 125.2 | 1,689,455 | Common Stock |
| Boston Properties Inc | Michael E. LaBelle | EVP and CFO | Sale of securities on an exchange or to another person at price $ 72.34 per share. | 07 Nov 2025 | 13,422 | 9,223 (0%) | 0% | 72.3 | 970,952 | Common Stock, par value $0.01 |
| RXO Inc | Thomas A. Szlosek | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2025 | 13,034 | 0 | - | 0 | Common Stock | |
| Evommune Inc | Eugene A. Bauer | Director, Chief Medical Officer | 07 Nov 2025 | 12,500 | 0 | - | - | Series B Preferred Stock | ||
| Evommune Inc | Janice Suzann Drew | EVP, Operations | 07 Nov 2025 | 12,500 | 0 | - | - | Series B Preferred Stock | ||
| Hologic | Brandon Schnittker | President, GYN Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 12,113 | 18,069 (0%) | 0% | - | Common Stock | |
| Snowflake Inc (Class A) | Michael L. Speiser | Director | Sale of securities on an exchange or to another person at price $ 257.00 per share. | 07 Nov 2025 | 12,098 | 518,904 | - | 257 | 3,109,186 | Common Stock |
| Astrana Health Inc | Mitchell W. Kitayama | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.20 per share. | 07 Nov 2025 | 12,000 | 27,846 (0%) | 0% | 18.2 | 218,400 | Common Stock |
| Astrana Health Inc | Mitchell W. Kitayama | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 12,000 | 0 | - | - | Stock Option (right to buy) | |
| Delek US Holdings Inc | Ezra Uzi Yemin | Director | Sale of securities on an exchange or to another person at price $ 43.09 per share. | 07 Nov 2025 | 11,861 | 154,719 (0%) | 0% | 43.1 | 511,090 | Common Stock |
| Driven Brands Holdings Inc | Muhammad Khalid | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.85 per share. | 07 Nov 2025 | 10,655 | 166,457 | - | 13.9 | 147,572 | Common Stock |
| Greenwich LifeSciences Inc | Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.43 per share. | 07 Nov 2025 | 10,600 | 5,583,502 | - | 8.4 | 89,358 | Common Stock |
| Rhythm Pharma Inc | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 10,546 | 7,035 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.80 per share. | 07 Nov 2025 | 10,546 | 40,165 (0%) | 0% | 6.8 | 71,713 | Common Stock |
| Zurn Elkay Water Soln Corp | Timothy J. Jahnke | Director | Sale of securities on an exchange or to another person at price $ 47.51 per share. | 07 Nov 2025 | 10,539 | 169,461 (0%) | 0% | 47.5 | 500,708 | Common Stock |
| LENZ Therapeutics Inc | James McCollum | Director | Purchase of securities on an exchange or from another person at price $ 22.79 per share. | 07 Nov 2025 | 10,500 | 10,500 | - | 22.8 | 239,278 | Common Stock |
| Energizer Holdings Inc | Robin W. Vauth | EVP, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 10,264 | 0 | - | - | Restricted Stock Unit Award 11/7/2022 | |
| Energizer Holdings Inc | Robin W. Vauth | EVP, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 10,264 | 20,091 (0%) | 0% | 0 | Common Stock | |
| Energizer Holdings Inc | Michael A Lampman | EVP, NA & Global Bus. Units | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 10,264 | 0 | - | - | Restricted Stock Unit Award 11/7/2022 | |
| Energizer Holdings Inc | Michael A Lampman | EVP, NA & Global Bus. Units | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 10,264 | 30,222 (0%) | 0% | 0 | Common Stock | |
| Marriott | Rena Reiss | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 10,110 | 0 | - | - | Stock Appreciation Rights | |
| Marriott | Rena Reiss | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 139.54 per share. | 07 Nov 2025 | 10,110 | 34,843 (0%) | 0% | 139.5 | 1,410,749 | Class A Common Stock |
| KKR Real Estate Finance Trust Inc | Christen E.J. Lee | Director | Purchase of securities on an exchange or from another person at price $ 7.80 per share. | 07 Nov 2025 | 10,000 | 229,133 (0%) | 0% | 7.8 | 77,978 | Common Stock |
| FS KKR Cap Corp | Daniel Pietrzak | Director, President and CIO | Purchase of securities on an exchange or from another person at price $ 15.15 per share. | 07 Nov 2025 | 10,000 | 59,800 (0%) | 0% | 15.2 | 151,500 | Common Stock |
| L.B. Foster Co. (Class A) | Brian H. Kelly | EVP and Sr. Advisor to the CEO | Sale of securities on an exchange or to another person at price $ 27.15 per share. | 07 Nov 2025 | 10,000 | 79,027 (0%) | 0% | 27.2 | 271,500 | Common Stock |
| Lineage Inc | Robert C. Crisci | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 34.56 per share. | 07 Nov 2025 | 10,000 | 107,859 | - | 34.6 | 345,630 | Common Stock |
| Crexendo Inc | Doug Gaylor | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 10,000 | 22,000 | - | - | Stock Options | |
| Crexendo Inc | Doug Gaylor | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 7.17 per share. | 07 Nov 2025 | 10,000 | 243,135 | - | 7.2 | 71,740 | Common stock |
| Crexendo Inc | Doug Gaylor | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.25 per share. | 07 Nov 2025 | 10,000 | 253,135 | - | 2.3 | 22,500 | Common Stock |
| Billiontoone Inc Ordinary | Thomas P. Lynch | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 10,000 | 0 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Thomas P. Lynch | See Remarks | Other type of transaction at price $ 0.00 per share. | 07 Nov 2025 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Marriott | Rena Reiss | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 124.79 per share. | 07 Nov 2025 | 10,000 | 44,843 (0%) | 0% | 124.8 | 1,247,900 | Class A Common Stock |
| Marriott | Rena Reiss | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 10,000 | 5,735 | - | - | Stock Appreciation Rights | |
| Greenlight Cap Re Ltd (Class A) | Thomas James Curnock | Grp Chief Underwriting Officer | Sale of securities on an exchange or to another person at price $ 12.58 per share. | 07 Nov 2025 | 9,942 | 169,890 (0%) | 0% | 12.6 | 125,070 | ORDINARY SHARES |
| Coherent Corp | Joseph J. Corasanti | Director | Sale of securities on an exchange or to another person at price $ 151.25 per share. | 07 Nov 2025 | 9,720 | 94,914 (0%) | 0% | 151.2 | 1,470,139 | Common Stock |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.10 per share. | 07 Nov 2025 | 9,427 | 109,776 (0%) | 0% | 74.1 | 698,541 | Common Stock |
| GigaCloud Tech Inc (Class A) | Xinyan Hao | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 33.24 per share. | 07 Nov 2025 | 9,359 | 737,446 | - | 33.2 | 311,119 | Class A Ordinary Shares, par value $0.05 per share |
| Energizer Holdings Inc | Lori A. Shambro | EVP, Brand&Product Innovation | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 9,238 | 37,393 (0%) | 0% | 0 | Common Stock | |
| Energizer Holdings Inc | Lori A. Shambro | EVP, Brand&Product Innovation | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 9,238 | 0 | - | - | Restricted Stock Unit Award 11/7/2022 | |
| JFrog Ltd | Frederic Simon | Director | Sale of securities on an exchange or to another person at price $ 60.39 per share. | 07 Nov 2025 | 9,213 | 3,984,903 | - | 60.4 | 556,373 | Ordinary Shares |
| SunCoke Energy Inc | Phillip Michael Hardesty | Senior Vice President | Purchase of securities on an exchange or from another person at price $ 6.64 per share. | 07 Nov 2025 | 9,168 | 262,683 (0%) | 0% | 6.6 | 60,876 | Common Stock |
| Customers Bancorp Inc | Bernard B. Banks | Director | Sale of securities on an exchange or to another person at price $ 66.93 per share. | 07 Nov 2025 | 9,000 | 7,524 (0%) | 0% | 66.9 | 602,370 | Common Stock |
| Guardant Health Inc | John G. Saia | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 96.25 per share. | 07 Nov 2025 | 8,996 | 43,172 (0%) | 0% | 96.3 | 865,865 | Common Stock |
| Ryman Hospitality Properties Inc | Colin V. Reed | Director, Exec. Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 92.16 per share. | 07 Nov 2025 | 8,993 | 888,010 (1%) | 0% | 92.2 | 828,814 | Common Stock |
| Rhythm Pharma Inc | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.02 per share. | 07 Nov 2025 | 8,805 | 29,619 (0%) | 0% | 19.0 | 167,471 | Common Stock |
| Rhythm Pharma Inc | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 8,805 | 5,257 | - | - | Stock Options (Right to Buy) | |
| Kaiser Aluminum Corp | Blain A. Tiffany | EVP - Sales & Marketing | Sale of securities on an exchange or to another person at price $ 93.92 per share. | 07 Nov 2025 | 8,656 | 26,275 (0%) | 0% | 93.9 | 812,997 | Common Stock, par value $0.01 per share |
| Skyworks | Reza Kasnavi | EVP, Chief Ops & Tech Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 8,581 | 33,151 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Sujata Dayal | Director | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 07 Nov 2025 | 8,552 | 88,980 (0%) | 0% | 10 | 85,520 | Common Stock |
| Capital Bancorp Inc | Scot R. Browning | Director, Pres, Specialty & CRE Lending | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.89 per share. | 07 Nov 2025 | 8,500 | 522,087 (3%) | 0% | 13.9 | 118,065 | Common Stock |
| Capital Bancorp Inc | Scot R. Browning | Director, Pres, Specialty & CRE Lending | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 8,500 | 0 | - | - | Stock Options | |
| Thermo Fisher | Lisa P. Britt | Sr. VP and Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 8,475 | 0 | - | - | Stock Option (Right to Buy) | |
| Thermo Fisher | Lisa P. Britt | Sr. VP and Chief HR Officer | Sale of securities on an exchange or to another person at price $ 571.67 per share. | 07 Nov 2025 | 8,475 | 14,144 (0%) | 0% | 571.7 | 4,844,904 | Common Stock |
| Thermo Fisher | Lisa P. Britt | Sr. VP and Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 253.99 per share. | 07 Nov 2025 | 8,475 | 22,619 (0%) | 0% | 254.0 | 2,152,565 | Common Stock |
| Energizer Holdings Inc | Sara B. Hampton | VP, Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 8,397 | 8,397 | - | - | Restricted Stock Unit Award 11/10/2025 | |
| Liquidia Corp | Dana Boyle | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 25.16 per share. | 07 Nov 2025 | 8,342 | 175,996 (0%) | 0% | 25.2 | 209,885 | Common Stock |
| Energizer Holdings Inc | Benjamin J. Angelette | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 8,211 | 24,861 (0%) | 0% | 0 | Common Stock | |
| Energizer Holdings Inc | Benjamin J. Angelette | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 8,211 | 0 | - | - | Restricted Stock Unit Award 11/7/2022 | |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 249.75 per share. | 07 Nov 2025 | 8,011 | 467,866 (0%) | 0% | 249.8 | 2,000,773 | ResMed Common Stock |
| Globus Medical Inc (Class A) | Ann D. Rhoads | Director | Sale of securities on an exchange or to another person at price $ 81.00 per share. | 07 Nov 2025 | 8,000 | 17,384 (0%) | 0% | 81 | 648,000 | Class A Common Stock |
| Amazon | Jamie S. Gorelick | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2025 | 7,944 | 38,117 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| Utz Brands Inc (Class A) | Dylan B. Lissette | Director | Purchase of securities on an exchange or from another person at price $ 9.99 per share. | 07 Nov 2025 | 7,901 | 153,684 | - | 10.0 | 78,909 | Class A Common Stock |
| JFrog Ltd | Frederic Simon | Director | Sale of securities on an exchange or to another person at price $ 57.78 per share. | 07 Nov 2025 | 7,900 | 4,064,251 | - | 57.8 | 456,462 | Ordinary Shares |
| Marriott | Rena Reiss | EVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 283.76 per share. | 07 Nov 2025 | 7,498 | 24,733 (0%) | 0% | 283.8 | 2,127,632 | Class A Common Stock |
| Zurn Elkay Water Soln Corp | Timothy J. Jahnke | Director | Sale of securities on an exchange or to another person at price $ 47.50 per share. | 07 Nov 2025 | 7,461 | 162,000 (0%) | 0% | 47.5 | 354,398 | Common Stock |
| Energizer Holdings Inc | John J. Drabik | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.84 per share. | 07 Nov 2025 | 7,460 | 56,477 (0%) | 0% | 23.8 | 177,846 | Common Stock |
| Lumentum Holdings Inc | Isaac H. Harris | Director | Sale of securities on an exchange or to another person at price $ 243.32 per share. | 07 Nov 2025 | 7,200 | 9,764 (0%) | 0% | 243.3 | 1,751,904 | Common Stock |
| Marriott | Rena Reiss | EVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 286.73 per share. | 07 Nov 2025 | 7,129 | 32,231 (0%) | 0% | 286.7 | 2,044,063 | Class A Common Stock |
| Idexx Laboratories | Nimrata Hunt | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 288.78 per share. | 07 Nov 2025 | 7,125 | 25,168 (0%) | 0% | 288.8 | 2,057,558 | Common Stock |
| Idexx Laboratories | Nimrata Hunt | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 7,125 | 0 | - | - | Non-Qualified Stock Option (right-to-buy) | |
| Skyworks | Robert J. Terry | SVP, Gen. Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2025 | 7,079 | 24,608 (0%) | 0% | 0 | Common Stock | |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 7,028 | 0 | - | - | ResMed Common Stock Options | |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 101.64 per share. | 07 Nov 2025 | 7,028 | 475,877 (0%) | 0% | 101.6 | 714,326 | ResMed Common Stock |
| Gladstone Commercial Corp | Arthur S. Cooper | President | Purchase of securities on an exchange or from another person at price $ 10.70 per share. | 07 Nov 2025 | 7,002 | 33,074 (0%) | 0% | 10.7 | 74,921 | Common Stock |
| Trinity Cap Inc | Kyle Brown | Director, CEO, President and CIO | Purchase of securities on an exchange or from another person at price $ 14.44 per share. | 07 Nov 2025 | 6,920 | 997,033 | - | 14.4 | 99,925 | Common Stock |
| Billiontoone Inc Ordinary | Nancy JoAnn Johnson | See Remarks | Purchase of securities on an exchange or from another person at price $ 60.00 per share. | 07 Nov 2025 | 6,900 | 35,900 | - | 60 | 414,000 | Class A Common Stock |
| Viavi Soln Inc | Eugenia M. Corrales | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 6,768 | 0 | - | - | Restricted Stock Unit | |
| Viavi Soln Inc | Eugenia M. Corrales | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 6,768 | 6,768 (0%) | 0% | 0 | Common Stock | |
| Stem Inc (Class A) | Michael James Carlson | President, Managed Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.27 per share. | 07 Nov 2025 | 6,743 | 17,384 | - | 18.3 | 123,195 | Common Stock, Par Value $0.0001 Per Share |
| Marriott | Satyajit Anand | President, EMEA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.86 per share. | 07 Nov 2025 | 6,724 | 30,894 (0%) | 0% | 66.9 | 449,567 | Class A Common Stock |
| Marriott | Satyajit Anand | President, EMEA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 6,724 | 0 | - | - | Stock Appreciation Rights | |
| Hologic | Stephen P. Macmillan | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.60 per share. | 07 Nov 2025 | 6,679 | 1,430,711 (0%) | 0% | 74.6 | 498,253 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.